Immunicom is developing a non-drug-based cancer therapy with the potential to reduce treatment side effects, enhance therapy response rates and improve cancer patients’ quality of life – all at significantly lower costs and without the side effects and complications prevalent in existing immunotherapy approaches. Immunicom's cancer therapy can allow the body’s natural immune system to directly attack cancer while enhancing the effects of other cancer treatments that may be used concurrently.

Biotechnology

Immunicom

Immunicom's headquarters in San Diego, CA, United States

Amir Jafri

Kamel Djazouli

Dave L. Lopez

Raju Chauhan

Julie Tubbs

Steven Josephs

Steve Prince

Michael Barrett

Michael E. Lehman

Peter C. Farrell

Gary Pace

D. John Miller

Wayne Jonas

The Leadership Team at Immunicom is responsible for guiding the strategic direction of the company and overseeing the development and implementation of its innovative cancer therapies. This team coordinates between departments to ensure operational efficiency, maintain high-quality standards in production, and drive commercial success while fostering a culture of collaboration and innovation. Their collective expertise in strategic programs, quality assurance, and scientific research enables Immunicom to advance its mission of providing effective, non-drug-based cancer treatments that enhance patient outcomes.

Leadership Team

The Business Operations team at Immunicom is responsible for streamlining and optimizing the company's processes to ensure operational efficiency and support the company's mission. This includes strategic planning, resource allocation, financial oversight, and performance management to facilitate the development and delivery of Immunicom's innovative cancer therapy. The team, led by multiple directors and supported by a senior business operations analyst, ensures that all business functions are aligned with corporate goals and regulatory requirements.

Business Operations

The Medical and Clinical Operations Team at Immunicom is responsible for overseeing clinical trials, regulatory compliance, and global medical affairs related to the company's innovative non-drug-based cancer therapy. This team ensures that clinical studies are conducted effectively and meet all regulatory standards, while also facilitating international medical collaboration and operational strategies to enhance cancer treatment outcomes.

Medical and Clinical Operations Team

The Quality Assurance Team at Immunicom is responsible for ensuring the highest standards of product quality and regulatory compliance in the development of the company's innovative, non-drug-based cancer therapy. They conduct thorough inspections, audits, and testing protocols to guarantee that every aspect of the therapy meets stringent quality criteria, thereby enhancing patient safety and treatment efficacy.

Immunicom

Org chart

Board & advisors

Teams

Leadership Team

Business Operations

Medical and Clinical Operations Team

Quality Assurance Team

Offices

Immunicom

Org chart

Board & advisors

Teams

Leadership Team

Business Operations

Medical and Clinical Operations Team

Quality Assurance Team

Offices

Related companies